TY - JOUR
T1 - Recent insights into the mechanisms of anaphylaxis
AU - Stevens, Whitney W.
AU - Kraft, Magdalena
AU - Eisenbarth, Stephanie C.
N1 - Funding Information:
MK is supported by the Walter Benjamin Fellowship from the German Research Foundation ( 464546188 ; KR 5534/1-1 ). WS is supported by K23AI141694, SCE is supported by R01AI136942, R56AI155497, FARE Foundation , Food Allergy Fund , and the Food Allergy Science Initiative .
Publisher Copyright:
© 2023 Elsevier Ltd
PY - 2023/4
Y1 - 2023/4
N2 - Anaphylaxis is an acute life-threatening systemic allergic reaction that can have a wide range of clinical manifestations. The most common triggers for anaphylaxis include food, medication, and venom. What is curious regarding anaphylaxis is how so many different agents can induce a severe systemic clinical response but only in a select subgroup of patients. Over the past decade, several important advances have been made in understanding the underlying cellular and molecular mechanisms contributing to anaphylaxis, with mast cells (MCs) being an essential component. Classically, cross-linked immunoglobulin E (IgE) bound to its high- affinity receptor induces MC mediator release. However, toll-like, complement, or Mas-related G-protein-coupled receptors also activate mouse and human MCs. While anaphylaxis secondary to foods historically has been more extensively characterized clinically and mechanistically, more recent studies have shifted focus toward understanding drug-induced anaphylaxis. The focus of this review is to highlight recent basic science developments and compare what is currently known regarding anaphylaxis to food, medications, and venom.
AB - Anaphylaxis is an acute life-threatening systemic allergic reaction that can have a wide range of clinical manifestations. The most common triggers for anaphylaxis include food, medication, and venom. What is curious regarding anaphylaxis is how so many different agents can induce a severe systemic clinical response but only in a select subgroup of patients. Over the past decade, several important advances have been made in understanding the underlying cellular and molecular mechanisms contributing to anaphylaxis, with mast cells (MCs) being an essential component. Classically, cross-linked immunoglobulin E (IgE) bound to its high- affinity receptor induces MC mediator release. However, toll-like, complement, or Mas-related G-protein-coupled receptors also activate mouse and human MCs. While anaphylaxis secondary to foods historically has been more extensively characterized clinically and mechanistically, more recent studies have shifted focus toward understanding drug-induced anaphylaxis. The focus of this review is to highlight recent basic science developments and compare what is currently known regarding anaphylaxis to food, medications, and venom.
UR - http://www.scopus.com/inward/record.url?scp=85148770605&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85148770605&partnerID=8YFLogxK
U2 - 10.1016/j.coi.2023.102288
DO - 10.1016/j.coi.2023.102288
M3 - Review article
C2 - 36848746
AN - SCOPUS:85148770605
SN - 0952-7915
VL - 81
JO - Current Opinion in Immunology
JF - Current Opinion in Immunology
M1 - 102288
ER -